Immunogenicity Testing Services
Risk assessment for biotherapeutics, NMEs, complex peptides
Key Facts
About Proimmune
ProImmune is a private, revenue-generating company headquartered in Oxford, UK, operating as a hybrid platform and services business in the immunology and diagnostics sectors. Its core technology is the Ankyron® platform, which produces small, high-specificity recombinant monoclonal binding reagents, complemented by a broad portfolio of MHC-related reagents and immunology testing services. The company serves a global clientele in pharmaceutical development and academic research, leveraging strategic collaborations, such as with the Roslin Institute, to expand into veterinary immunology and strengthen its market position. ProImmune also fosters industry engagement through events like its 'Mastering Immunity' symposium series.
View full company profile